Non-Current Assets
Net Investment in Lease
Edwards Lifesciences Net Investment in Lease decreased by 3.3% to $99.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $96.90M to $99.30M. Over 5 years (FY 2020 to FY 2025), Net Investment in Lease shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase indicates growth in the bank's leasing business, while a decrease suggests a contraction in this lending segment.
Detailed definition
This represents the present value of future lease payments receivable from lessees, plus the unguaranteed residual value...
Peer comparison
Common among diversified regional banks with strong commercial and industrial lending divisions.
Metric ID:
net_investment_in_leaseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.60M | $84.80M | $92.10M | $90.10M | $84.20M | $87.70M | $92.30M | $88.50M | $84.90M | $90.90M | $84.40M | $98.40M | $92.80M | $104.40M | $98.20M | $96.90M | $99.00M | $96.50M | $102.70M | $99.30M |
| QoQ Change | — | +0.2% | +8.6% | -2.2% | -6.5% | +4.2% | +5.2% | -4.1% | -4.1% | +7.1% | -7.2% | +16.6% | -5.7% | +12.5% | -5.9% | -1.3% | +2.2% | -2.5% | +6.4% | -3.3% |
| YoY Change | — | — | — | — | -0.5% | +3.4% | +0.2% | -1.8% | +0.8% | +3.6% | -8.6% | +11.2% | +9.3% | +14.9% | +16.4% | -1.5% | +6.7% | -7.6% | +4.6% | +2.5% |
Range$84.20M – $104.40M
CAGR+3.4%
Avg YoY Growth+3.4%
Median YoY Growth+2.9%
Net Investment in Lease at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's net investment in lease?
- Edwards Lifesciences (EW) reported net investment in lease of $99.30M in Q1 2026.
- How has Edwards Lifesciences's net investment in lease changed year-over-year?
- Edwards Lifesciences's net investment in lease increased by 2.5% year-over-year, from $96.90M to $99.30M.
- What is the long-term trend for Edwards Lifesciences's net investment in lease?
- Over 5 years (2020 to 2025), Edwards Lifesciences's net investment in lease has grown at a 1.7% compound annual growth rate (CAGR), from $94.20M to $102.70M.
- What does net investment in lease mean?
- The total amount owed to the bank by customers under lease agreements, adjusted for present value.